These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Hypersensitivity to para-amino salysilic acid (P.A.S.). Report of a fatal case]. FILOZ-DIAZ JA; YOUNG RV; LINDLEY SK Arch Med Panamenos; 1963 Apr; 12():68-76; also 59-67. PubMed ID: 13945189 [No Abstract] [Full Text] [Related]
9. [ENCEPHALITIS AS A CONSEQUENCE OF PAS SENSITIZATION]. SWICOWA K; GOLEDZINOWSKA L Pol Tyg Lek; 1963 Nov; 18():1732-3. PubMed ID: 14121572 [No Abstract] [Full Text] [Related]
10. [On 2 cases of acute hemolytic anemia caused by PAS administration; clinico-pathogenetic remarks]. BALSAMO V Riv Clin Pediatr; 1962 Jun; 69():368-76. PubMed ID: 13966237 [No Abstract] [Full Text] [Related]
12. THE DETECTION OF HUMORAL ANTIBODIES DIRECTED AGAINST SALICYLATES IN HYPERSENSITIVE STATES. WEINER LM; ROSENBLATT M; HOWES HA J Immunol; 1963 May; 90():788-92. PubMed ID: 14053297 [No Abstract] [Full Text] [Related]
13. Liver "autoantibodies" in a case of drug-induced jaundice. GOKCEN M; ZINNEMAN HH Gastroenterology; 1963 Jan; 44():69-72. PubMed ID: 13948619 [No Abstract] [Full Text] [Related]
14. [Allergic, immunohemolytic anemia due to para-aminosalicylic acid (PAS). Immunohematologic studies of three cases]. Mueller-Eckhardt C; Kretschmer V; Coburg KH Dtsch Med Wochenschr; 1972 Feb; 97(7):234-8 passim. PubMed ID: 5058584 [No Abstract] [Full Text] [Related]
15. [Harmlessness of resumption of PAS therapy after a hemolytic accident; pathogenic considerations]. CASTANIER J; MALMEJAC R; PARIENTE P; MALAVAUD M Pediatrie; 1955; 10(7):782-5. PubMed ID: 13310132 [No Abstract] [Full Text] [Related]
16. [Immunity and allergy depression during rubella in a child with primary tuberculosis and isoniazid intolerance]. Tournier G; Grunberg J; Hanoteau J; Gerbeaux J Ann Med Interne (Paris); 1972 Nov; 123(11):931-6. PubMed ID: 4540667 [No Abstract] [Full Text] [Related]
17. Atrial fibrillation due to hypersensitivity to para-aminosalicylic acid. HUBAYTAR RT; SIMPSON DG Am Rev Respir Dis; 1962 Nov; 86():720-2. PubMed ID: 13955374 [No Abstract] [Full Text] [Related]
18. [The choice of drug to be combined with INH in the initial drug therapy of tuberculosis patients]. BOSZORMENYI M; FAUSZT I; BARABAS M; BARAT I; JAKAB Z; MAJZIK G; SCHWEIGER O Tuberkulozis; 1962 Dec; 15():360-4. PubMed ID: 14014238 [No Abstract] [Full Text] [Related]
19. [Allergic blood diseases]. FLEISCHHACKER H Wien Klin Wochenschr; 1963 Feb; 75():77-80. PubMed ID: 13945468 [No Abstract] [Full Text] [Related]
20. [RESEARCH ON THE METABOLISM OF POTASSIUM IN TUBERCULOUS PATIENTS TREATED WITH P.A.S]. SALA L Friuli Med; 1963; 18():301-11. PubMed ID: 14051709 [No Abstract] [Full Text] [Related] [Next] [New Search]